Academia-Industry Dialogs

This forum gathers academic and industry scientists to discuss best practices, protocols and challenges with new technologies (such as iPSCs, CRISPR/Cas9 gene editing, and 3D-culturing) to generate improved predictive models of neurological disease. In facilitated discussion we seek to find ways how academia and industry can better address the challenges of translation of the basic research findings into transformative therapies. We invite all members of the Boston area academic and research community interested in the novel research in neurological disease to join in this series of discussions.

Group coordinators: Evgenii Kegeles (graduate student, lab of Zhigang He, Boston Children’s Hospital), Daniela Di Bella, PhD (postdoctoral fellow, lab of Paola Arlotta, Harvard), and Elisa Pavarino (graduate student, lab of Gabriel Kreiman, Boston Children’s Hospital).